United States  

South Asia faces a remittances crisis amid COVID-19 pandemic

Video Credit: Al Jazeera STUDIO - Duration: 02:06s - Published
South Asia faces a remittances crisis amid COVID-19 pandemic

South Asia faces a remittances crisis amid COVID-19 pandemic

Coronavirus lockdowns cost millions of migrant workers their jobs, halting billions in remittances they sent home.

0
shares
ShareTweetSavePostSend
 

💡 One News Page Knowledge: Other News Mentions

South Asia South Asia Southern region of Asia

South Asia monsoon: More than 130 people killed in Nepal floods [Video]

South Asia monsoon: More than 130 people killed in Nepal floods

The monsoon season in Nepal started last month, then took a turn for the worse on Sunday.

Credit: Al Jazeera STUDIO    Duration: 02:06Published
India coronavirus infections top one million [Video]

India coronavirus infections top one million

India saw record cases on Friday, as Red Cross warned the virus was spreading at 'an alarming rate' across South Asia.

Credit: Al Jazeera STUDIO    Duration: 02:05Published
Nepal needs to be careful of China's tactics: Central Tibetan Administration [Video]

Nepal needs to be careful of China's tactics: Central Tibetan Administration

Lobsang Sangay, the President of Central Tibetan Administration has warned Nepal to be careful from China's tactic of elite co-optation. He made this statement over the question asked on the recent closeness between Nepal and China. "We lost our country because of elite co-optation and China's tactic of elite co-optation takes place everywhere in the world, including in South Asia and Nepal. So be careful," said Lobsang Sangay while talking to ANI in Dharamshala on June 25. The CTA is also referred to as the Tibetan Government in Exile which has never been recognized by China.

Credit: ANI    Duration: 01:20Published

Coronavirus Coronavirus Subfamily of viruses in the family Coronaviridae

Frontier CEO says CDC should update coronavirus travel advice: 'Flying is not dangerous'

The CDC says travel increases the chance of getting and spreading COVID-19. It also says most viruses don't spread easily on flights.

USATODAY.com

AP Top Stories August 7 A

Here's the latest for Friday August 7th: Coronavirus relief deal talks described as close to collapsing; Mexico records 50,000 coronavirus deaths; Unlawful..
USATODAY.com

CBS Evening News, August 6, 2020

Coronavirus model projects U.S. death toll could hit 300,000 by December;
CBS News

'We're very far apart': Coronavirus relief negotiations left in uncertainty after Congress leaves for the weekend

Both sides push for a compromise by the end of the week, but progress on a deal has bogged down.

USATODAY.com
Alcoholism treatment is potentially effective against COVID-19 [Video]

Alcoholism treatment is potentially effective against COVID-19

A team of chemists from HSE University and the Zelinsky Institute of Organic Chemistry used molecular modelling to find out that two medications that have been known for a long time can be used to fight SARS-CoV-2. These are disulfiram, which is used to treat alcoholism, and neratinib, an experimental drug being used to treat breast cancer. The paper about the discovery has been published online in the 4th issue of Mendeleev Communications journal.The structural elements of the virus that are less subject to mutation during its evolution should be chosen as a target for the potential treatment. Otherwise, a medication effective against one strain would no longer be effective against another. The best candidates for this are conservative proteins, such as the SARS-CoV-2 virus main protease M pro. In addition to being resistant to mutations, M pro plays a major role in coronavirusreplication, which means that its inhibition (blocking its function) is able to slow down or even completely stop its reproduction inside the body.Usually, the process of docking, as with a port dock and a ship entering it, is used for molecular modelling in simple cases. Two molecules participate in docking. One is called a 'ligand' (here, it is a medicine), and the other one is 'receptor' (or active site) of the target protein, such as Mpro, which can be used to 'dock'. An effective drug docks with the active site, by covalent links, which makes the enzyme dysfunctional or destroys it. But classical docking does not work in SARS-CoV-2.To overcome this problem, chemists from HSE University and the Zelinsky Institute decided to use 'on-top docking', which they came up with shortly before the pandemic. 'We decided not to focus on the previously described active site, but to investigate the whole surface of M pro protein with many medications, hoping that the big calculation powers would return useful "dockings",' - said Igor Svitanko, the author of the article,Professor at the HSE Joint Department of Organic Chemistry with the RAS Zelinsky Institute of Organic Chemistry.

Credit: ANI    Duration: 01:10Published

You Might Like


Tweets about this